Sidley has advised Opus Genetics on the deal. Opus Genetics, Inc., a clinical-stage gene therapy company focused on inherited retinal diseases, has entered into a strategic...
Opus Genetics Secures $155 Million Structured Financing from Oberland Capital
Permira and CPP Investments Agree £2.3 Billion Acquisition of JTC plc
Clifford Chance and Sidley Austin have advised Permira; Linklaters has advised CPP Investments; White & Case has advised JTC plc. Permira, supported by the Canada Pension...
Sagard Healthcare Partners’ $250 Million Non-Dilutive Financings to Nuvation Bio
Cooley represented Nuvation Bio in the transaction, and Sidley Austin represented Sagard Healthcare Partners. Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the...
Verona Pharma’s $650 Million Financing Round
Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
Wafra’s Acquisition of Aquila Air Capital
Sidley Austin is representing Wafra Inc. in the transaction, and Kirkland & Ellis is representing Aquila Air Capital. Wafra Inc. (“Wafra”), a New York-based, global alternative...
Apollo Global’s $6.3 Billion Acquisition of Everi and IGT Gaming
Sidley Austin , White & Case and Wachtell, Lipton, Rosen & Katz are advising International Game Technology PLC on the transaction, and Paul, Weiss, Rifkind, Wharton...
IGT’s US$6.2 Billion Business Combination of Its Global Gaming Business with Everi
Sidley Austin LLP and White & Case LLP are serving as legal counsel to IGT, Wachtell, Lipton, Rosen & Katz is serving as counsel to IGT...